CYP1A2 and bladder transitional cell carcinoma: Consequently, the current study seeks to assess the relationship between the CYP1A2-163 C/A polymorphism and BLCA risk, as well as to comprehensively evaluate the potential associations of specific SNPs within the CYP1A2 gene with the risk of BLCA.